Advertisement

Apoptosis

, Volume 12, Issue 8, pp 1433–1441 | Cite as

Involvement of PDCD5 in the regulation of apoptosis in fibroblast-like synoviocytes of rheumatoid arthritis

  • Ning Wang
  • Hou-Shan LuEmail author
  • Zhen-Peng Guan
  • Tie-Zheng Sun
  • Ying-Yu Chen
  • Guo-Rui Ruan
  • Zhan-Kun Chen
  • Jun Jiang
  • Chu-Jie Bai
Original paper

Abstract

Apoptosis is reduced in the synovial tissue of patients with rheumatoid arthritis (RA), possibly due to decreased expression of pro-apoptotic genes. Programmed Cell Death 5 (PDCD5) has been recently identified as a protein that mediates apoptosis. Although PDCD5 is down-regulated in many human tumors, the role of PDCD5 in RA has not been investigated. Here we report that reduced levels of PDCD5 mRNA and protein are detected in RA synovial tissue (ST) and fibroblast-like synoviocytes (FLS) than in tissue and cells from patients with osteoarthritis (OA). We also report differences in the PDCD5 expression pattern in tissues from patients with these two types of arthritis. PDCD5 showed a scattered pattern in rheumatoid synovium compared with OA, in which the protein labeling was stronger in the synovial lining layer than in the sublining. We also observed increased expression and nuclear translocation of PDCD5 in RA patient-derived FLS undergoing apoptosis. Finally, overexpression of PDCD5 led to enhanced apoptosis and activation of caspase-3 in triptolide-treated FLS. We propose that PDCD5 may be involved in the pathogenesis of RA. These data also suggest that PDCD5 may serve as a therapeutic target to enhance sensitivity to antirheumatic drug-induced apoptosis in RA.

Keywords

Rheumatoid arthritis Fibroblast-like synoviocytes PDCD5 Apoptosis Gene transfer 

Notes

Acknowledgments

This work was supported by grants from the National Basic Research Program (973 Program, 2002CB513000) and the National Natural Science Foundation of China (30470844). The authors thank Prof. Da-Long Ma (Peking University, Beijing) for advice and guidance. Conflict of Interest: The authors declare that they have no competing interests.

References

  1. 1.
    Firestein GS (2003) Evolving concepts of rheumatoid arthritis [review]. Nature 423:356–361PubMedCrossRefGoogle Scholar
  2. 2.
    Pap T, Müller-Ladner U, Gay RE, Gay S (2000) Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2:361–367PubMedCrossRefGoogle Scholar
  3. 3.
    Baier A, Meineckel I, Gay S, Pap T (2003) Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 15:274–279PubMedCrossRefGoogle Scholar
  4. 4.
    Liu HT, Wang YG, Zhang YM et al (1999) TFAR19, a novel apoptosis-related gene cloned from human leukemia cell lineTF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254:203–210PubMedCrossRefGoogle Scholar
  5. 5.
    Rui M, Chen YY, Zhang YM, Ma DL (2002) Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis. Life Sci 71:1771–1778PubMedCrossRefGoogle Scholar
  6. 6.
    Chen YY, Sun RH, Han WL et al (2001) Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509:191–196PubMedCrossRefGoogle Scholar
  7. 7.
    Hedenfalk I, Duggan D, Chen Y et al (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344:539–548PubMedCrossRefGoogle Scholar
  8. 8.
    Xu XR, Huang J, Xu ZG et al (2001) Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98:15089–15094PubMedCrossRefGoogle Scholar
  9. 9.
    Yang YH, Zhao M, Li WM, Chen YY, Kang B, Lu YY (2006) Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 11:993–1001PubMedCrossRefGoogle Scholar
  10. 10.
    Ma X, Ruan GR, Wang Y, Li QY, Ma DL, Zhao HS (2005) Two single-nucleotide polymorphisms with linkage disequilibrium in the human PDCD5 gene 5’ regulatory region affect promoter activity and the susceptibility of CML in Chinese population. Clin Cancer Res 11:8592–8599PubMedCrossRefGoogle Scholar
  11. 11.
    Spinola M, Meyer P, Kammerer S et al (2006) Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J Clin Oncol 24:1672–1678PubMedCrossRefGoogle Scholar
  12. 12.
    Cheng AX, Lou SQ, Zhou HW, Wang Y, Ma DL (2004) Expression of PDCD5, a novel apoptosis related protein, in human osteoarthritic cartilage. Acta Pharmacol Sin 25:685–690PubMedGoogle Scholar
  13. 13.
    Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  14. 14.
    Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049PubMedCrossRefGoogle Scholar
  15. 15.
    Gravallese EM, Manning C, Tsay A et al (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250–258PubMedCrossRefGoogle Scholar
  16. 16.
    Ruan GR, Qin YZ, Chen SS et al (2006) Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Leuk Res 30:1159–1165PubMedGoogle Scholar
  17. 17.
    Kusunoki N, Yamazaki R, Kitasato H, Beppu M, Aoki H, Kawai S (2004) Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC Pharmacol 4:1–10CrossRefGoogle Scholar
  18. 18.
    Pope RM (2002) Apoptosis as a therapeutic tool in rheumatoid arthritis [review]. Nat Rev Immunol 2:527–535PubMedCrossRefGoogle Scholar
  19. 19.
    Antonsson B, Martinou JC (2000) The Bcl-2 protein family. Exp Cell Res 256:50–57PubMedCrossRefGoogle Scholar
  20. 20.
    Deng YB, Lin YH, Wu XW (2002) TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16:33–45PubMedCrossRefGoogle Scholar
  21. 21.
    Deveraux QL, Reed JC (1999) IAP family proteins-suppressors of apoptosis. Genes Dev 13:239–252PubMedGoogle Scholar
  22. 22.
    Irmler M, Thome M, Hahne M et al (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190–195PubMedCrossRefGoogle Scholar
  23. 23.
    Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S (2000) Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2:59–64PubMedCrossRefGoogle Scholar
  24. 24.
    Franz JK, Pap T, Hummel KM et al (2000) Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 43:599–607PubMedCrossRefGoogle Scholar
  25. 25.
    Schedel J, Gay RE, Kuenzler P et al (2002) FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum 46:1512–1518PubMedCrossRefGoogle Scholar
  26. 26.
    Catrina AI, Ulfgren AK, Lindblad S, Grondal L, Klareskog L (2002) Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann Rheum Dis 61:934–936PubMedCrossRefGoogle Scholar
  27. 27.
    Seemayer CA, Kuchen S, Neidhart M et al (2003) p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion. Ann Rheum Dis 62:1139–1144PubMedCrossRefGoogle Scholar
  28. 28.
    Cha HS, Rosengren S, Boyle DL, Firestein GS (2006) PUMA regulation and proapoptotic effects in fibroblast-like synoviocytes. Arthritis Rheum 54:5879–592CrossRefGoogle Scholar
  29. 29.
    Perlman H, Georganas C, Pagliari LJ, Koch AE, Haines K III, Pope RM (2000) Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability. J Immunol 164:5227–5235PubMedGoogle Scholar
  30. 30.
    Perlman H, Liu H, Georganas C et al (2001) Differential expression pattern of the antiapoptotic proteins, Bcl-2 and FLIP, in experimental arthritis. Arthritis Rheum 44:2899–2908PubMedCrossRefGoogle Scholar
  31. 31.
    Zhang HG, Huang N, Liu D et al (2000) Gene therapy that inhibits nuclear translocation of nuclear factor (B results in tumor necrosis factor α-induced apoptosis of human synovial fibroblasts. Arthritis Rheum 43:1094–1105PubMedCrossRefGoogle Scholar
  32. 32.
    Chen LN, Wang Y, Ma DL, Chen YY (2006) Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 11:101–111PubMedCrossRefGoogle Scholar
  33. 33.
    Wang Y, Li XT, Wang L et al (2004) An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 117:1525–1532PubMedCrossRefGoogle Scholar
  34. 34.
    Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S (1996) Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 23:1345–1352PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Ning Wang
    • 1
  • Hou-Shan Lu
    • 1
    Email author
  • Zhen-Peng Guan
    • 1
  • Tie-Zheng Sun
    • 1
  • Ying-Yu Chen
    • 2
  • Guo-Rui Ruan
    • 3
  • Zhan-Kun Chen
    • 1
  • Jun Jiang
    • 1
  • Chu-Jie Bai
    • 1
  1. 1.Arthritis Institute, People’s HospitalPeking UniversityBeijingP.R. China
  2. 2.Center for Human Disease GenomicsPeking UniversityBeijingP.R. China
  3. 3.Institute of Hematology, People’s HospitalPeking UniversityBeijingP.R. China

Personalised recommendations